ADAMTS16 and myocardial infarction: These anti-fibrotic properties also were observed in a rat myocardial infarction model where miR-29b-3 targeted ADAM with thrombospondin motifs 16 (ADAMTS16), a promoter of cardiac myofibroblasts that regulates angiogenic ventricular remodeling [48].